SEC Comment Letter for BRAINSTORM CELL THERAPEUTICS INC. (BCLI) (CIK 0001137883) (BCLI) — Mar 13, 2006

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) (CIK 0001137883)
Date: March 13, 2006 · CIK: 0001137883 · Accession: 0000000000-06-012130

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-61610

Date

March 13, 2006

Author

Kevin Woody

Form

UPLOAD

Company

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) (CIK 0001137883)

Letter

Via Facsimile and U.S. Mail Mail Stop 6010 March 13, 2006 Mr. Yoram Drucker Chief Operating Officer Brainstorm Cell Therapeutics Inc. 1350 Avenue of the Americas New York, NY 10019

Re: Brainstorm Cell Therapeutics Inc. Form 10-KSB for Fiscal Year Ended March 31, 2005 File No. 333-61610

Dear Mr. Drucker: We have completed our review of your Form 10-KSB and have no further comments at this time.

S i n c e r e l y , Kevin Woody B r a n c h C h i e f

Show Raw Text

Via Facsimile and U.S. Mail Mail Stop 6010                                                                                                   March 13, 2006
Mr. Yoram Drucker
Chief Operating Officer
Brainstorm Cell Therapeutics Inc.
1350 Avenue of the Americas
New York, NY  10019

Re: Brainstorm Cell Therapeutics Inc.
 Form 10-KSB for Fiscal Year Ended March 31, 2005
File No. 333-61610

Dear Mr. Drucker:
  We have completed our review of your Form 10-KSB and have no further
comments at this time.

        S i n c e r e l y ,
Kevin Woody
        B r a n c h  C h i e f

SecProbe.io